Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt

In the spring of 2024, weighing 210 pounds and on medication to reduce his blood pressure, Dan Sherry was prescribed Ozempic.Today Mr.Sherry, 58, weighs 160 pounds and his blood pressure is under control.

He bikes daily and his waist is six inches smaller.One of the biggest changes to his lifestyle has been his eating habits.Mr.

Sherry, a nurse who lives in Holland, Mich., eats out less frequently, and when he does go out with friends, he drinks less alcohol and typically eats only half of his meal.He eats fewer French fries than he once did.At the supermarket, he puts more meat and protein shakes in his cart while a bag of Cape Cod Sea Salt & Vinegar chips has become “a rare splurge.”The growing use of GLP-1s is reshaping consumer behavior and shopping patterns across a multitude of industries.

But perhaps no sector faces as sweeping a transformation from the weight-loss drugs as does the food industry.“My grocery food bill is probably 10 to 15 percent less,” Mr.Sherry said.

“The biggest spending was on new clothes.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access.If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe....